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 Ketamine attenuated the excitatory postsynaptic responses evoked by nerve stimulation in 
a concentration-dependent manner.  
 This reduction was significant at clinically relevant concentrations at high frequencies. 
 Ketamine inhibits nicotinic acetylcholine receptor-mediated currents in dissociated rat 
intracardiac ganglion (ICG) neurons. 
 Ketamine inhibits cholinergic synaptic transmission in the rat ICG accounting for 




The intravenous anaesthetic ketamine, has been demonstrated to inhibit nicotinic 
acetylcholine receptor (nAChR)-mediated currents in dissociated rat intracardiac ganglion 
(ICG) neurons (Weber et al., 2005). This effect would be predicted to depress synaptic 
transmission in the ICG and would account for the inhibitory action of ketamine on vagal 
transmission to the heart (Inoue and König, 1984). This investigation was designed to 
examine the activity of ketamine on (i) postsynaptic responses to vagal nerve stimulation, (ii) 
the membrane potential, and (iii) membrane current responses evoked by exogenous 
application of ACh and nicotine in ICG neurons in situ. Intracellular recordings were made 
using sharp intracellular microelectrodes in a whole mount ICG preparation. Preganglionic 
nerve stimulation and recordings in current- and voltage-clamp modes were used to assess the 
action of ketamine on ganglionic transmission and nAChR-mediated responses. Ketamine 
attenuated the postsynaptic responses evoked by nerve stimulation. This reduction was 
significant at clinically relevant concentrations at high frequencies. The excitatory membrane 
potential and current responses to focal application of ACh and nicotine were inhibited in a 
concentration-dependent manner by ketamine. In contrast, ketamine had no effect on the 
directly-evoked action potential or excitatory responses evoked by focal application of γ-
aminobutyric acid (GABA). Taken together, ketamine inhibits synaptic transmission and 
nicotine- and ACh-evoked currents in adult rat ICG. Ketamine inhibition of synaptic 
transmission and nAChR-mediated responses in the ICG contributes significantly to its 
attenuation of the bradycardia observed in response to vagal stimulation in the mammalian 
heart.  
Keywords: anaesthesia; intrinsic cardiac ganglia; ketamine; nicotinic acetylcholine receptor; 
synaptic transmission; action potential; calcium channels; vagal nerve stimulation 
Abbreviations: [Ca
2+
]i, intracellular calcium ion concentration; dSEVC, discontinuous single
electrode voltage clamp; EPSP, excitatory postsynaptic potential; IACh, ACh-evoked current; 
IC50, half-maximal inhibitory concentration; ICG, intracardiac ganglion; nAChR, nicotinic 





Ketamine is used as an anaesthetic and analgesic in clinical and veterinary practice, and 
similarly in animal research.  Since its activity is rapid in onset and short lived, it is ideal for 
brief surgical operations and is used in conflict zones and disaster situations (Trelles 
Centurion et al., 2017). In addition, the risk of overdose is small and hence few complications 
are associated with its use. Ketamine is used in human surgery in adults and pediatric 
patients, being listed in the WHO Essential Medicine List since 1985 (WHO Model List of 
Essential Medicines, 2017). The principal target for the action of ketamine is generally held 
to be its antagonist action at the N-methyl-D-aspartate (NMDA) receptor (Anis et al., 1983; 
Lodge and Mercier, 2015). Ketamine, however, has been demonstrated to interact with 
several other neurotransmitter receptors and ion channels (Zanos et al., 2018) including 
opioid and muscarinic acetylcholine receptors (in particular, M1) and can have anaesthetic 
effects on voltage-gated Na
+
 channels (Sinner and Graf, 2008). 
The intravenous (i.v.) dissociative anaesthetic ketamine is known to affect cardiac 
parameters such as heart rate and cardiac output under clinical conditions (Tweed et al., 
1972) and in chronically instrumented animals (Akine et al., 2001; Blake and Korner, 1981, 
1982; Inoue and Arndt, 1982). Ketamine also has a direct effect on cardiac muscle, 
decreasing myocardial contractility, but only at supratherapeutic ketamine doses (~100 M) 
(Sprung et al., 1998). Considering autonomic regulation, excitatory neurotransmission in 
guinea-pig sympathetic ganglia is blunted by ketamine (Juang et al., 1980; Mahmoodi et al., 
1980). This effect is overridden by the stimulation of a central sympathetic response 
sustaining or increasing blood pressure (Kurdi et al., 2014). However, ketamine inhibition of 
parasympathetic neurons involved in the regulation of cardiac function may contribute to the 
increase in heart rate (Inoue and König, 1988). Ketamine has been shown to inhibit nicotinic 
excitation in cardiac preganglionic parasympathetic neurons of the nucleus ambiguus of the 
brainstem (Irnaten et al., 2002). Postganglionic intracardiac neurons have also been shown to 
modulate heart rate in a nicotine-dependent manner, demonstrating the involvement of 
neuronal nicotinic acetylcholine receptors (nAChRs) (Bibevski et al., 2000; Ji et al., 2002). 
Ketamine inhibits reversibly and stereo-specifically neuronal nAChRs in rat PC12 cells 
(Sasaki et al., 2000) and human SH-SY5Y cells (Friederich et al., 2000). Furthermore, bath 
application of ketamine has been shown to cause a concentration-dependent inhibition of 




]i) in rat ICG neurons 
(Weber et al., 2005). At a clinically relevant concentration, ketamine (10 M) reversibly 
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inhibited ACh-induced increases in [Ca
2+
]i but failed to inhibit increases in [Ca
2+
]i evoked by 
focal application (100 M) of either muscarine or ATP. Taken together, ketamine would be 
predicted to reduce the excitatory postsynaptic potential (EPSP) amplitude and depress 
synaptic transmission in the ICG and would account for the action of ketamine on peripheral 
vagal transmission to the heart (Inoue and König, 1988). We have directly tested this proposal 
by investigating the actions of ketamine on postsynaptic responses to vagal nerve stimulation 
and exogenous ACh and nicotine in ICG neurons in a whole mount ganglion preparation of 
the excised right atrial ganglion plexus from the adult rat. A preliminary account of the 
results has been given in a published abstract (Harper et al., 2006).
 
 
Material and Methods 
Preparation 
Animal studies are reported in compliance with the ARRIVE guidelines (Kilkenny et al., 
2010). The whole mount ICG preparation has been described previously (Rimmer and 
Harper, 2006). Briefly, twenty young, non-pregnant, female adult Wistar rats (≥ 6 wk, 125–
220 g) were used. The University of Dundee is a designated scientific establishment 
(certificate of designation no. 60/2602) under the Animals (Scientific Procedures) Act 1986 
(‘the Act’). Rats were obtained from a designated supplier in the UK (Harlan UK Ltd., Oxon, 
UK) and were housed and cared for according to Home Office Guidelines on the Operation 
of the Act. Animals were killed by concussion and cervical dislocation, as authorised in 
Schedule 1 to the Act. No formal prior approval is required for Schedule 1 kill. The Ethics 
Committee does, however, conduct a Census of Schedule 1 procedures.  
A whole mount preparation comprising the right atrial ganglion plexus and underlying 
myocardium was pinned out in a recording chamber (∼1.0 ml volume) lined with Sylgard 
184 silicone elastomer (Dow Corning) and superfused with bicarbonate buffered 
physiological salt solution (PSS) at ∼2 ml/min (Gilson Minipuls 3; Gilson, Middleton WI, 
USA). The temperature of the superfusing solution was controlled by a Peltier heating device 
(PDMI-2 micro incubator; Medical Systems Corp., Greenvale NY, USA) to 36°C, monitored 
by an independent thermistor probe in the recording chamber. The tissue was left to 
resuscitate in these conditions for ∼30 min before commencing electrophysiological 
recording. ICG neurons were visualized using differential interference contrast (DIC) optics 
on a fixed stage microscope. Recordings were normally made from the sino-atrial ganglion, 
the largest located at the junction of the right superior vena cava and right atrium (Rimmer 
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and Harper, 2006). 
 
Electrophysiological recording, data acquisition and analysis 
Intracellular recordings from postganglionic ICG somata were made using sharp 
microelectrodes pulled from borosilicate glass (GC120F; Harvard Apparatus, Holliston MA, 
USA) with DC resistances of ∼120 MΩ when filled with 0.5 M KCl (0.5 M K acetate for 
GABA procedures). Membrane voltage and current responses were recorded with single 
microelectrode clamp amplifiers, Axoclamp 2A (Axon Instruments Inc., Foster City, CA 
USA) and NPI SEC-05X (npi electronic GmbH, Tamm, Germany). Voltage and current 
signals were digitized at 50 kHz and 10 kHz, respectively, and transferred to a dual-core 
Pentium computer using an analog-to-digital converter [Micro 1401 Mk II interface; 
Cambridge Electronic Design (CED), Cambridge, UK] and Spike 2, version 6/7 software 
(CED). 
Branches of the vagus and interganglionic nerve trunks were stimulated using a glass 
suction electrode fabricated from borosilicate glass (GC150F; Harvard Apparatus) connected 
to a constant voltage isolated stimulator (Digitimer DS2; Digitimer Ltd., Welwyn Garden 
City, UK). Nerve trunks were stimulated using stimulus pulses of 0.02 to 0.2 ms width and 5 
– 50 V amplitude. ACh, nicotine and GABA (100 µM) were focally applied using a pressure-
ejection device (∼150 kPa; Picospritzer II, General Valve Corp. Fairfield, NJ, USA), and the 
pressure ejection pipette was positioned <50 μm from the neuronal soma to maximize the 
response to agonist application. The pulse was adjusted to the shortest possible duration, 
consistent with the peak voltage or current responses being unchanged with a rapid recovery 
to control levels. 
 
Solutions and pharmacological agents  
PSS contained (in mM): 118 NaCl, 25 NaHCO3, 1.13 NaH2PO4, 4.7 KCl, 1.8 CaCl2, 1.3 
MgCl2, 11.1 D-glucose and was gassed with carbogen (95% O25% CO2) to pH 7.4. All 
reagents were of analytical grade. Vetalar ((±)-ketamine hydrochloride, 100 mg/ml, also 
containing 0.1% w/v benzthonium chloride as a preservative) obtained from Pfizer 
(Sandwich, Kent, UK) was dissolved immediately before application in PSS at the 
concentrations stated. 
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Data and statistical analysis 
Data were acquired at two time points in control conditions, and following 20 mins 
superfusion of ketamine or upon recovery to control PSS solution. The reported actions of 
ketamine were investigated in no more than one ICG neuron in each preparation. Data are 
presented as the means ± SD of the number of observations (individual neurons, n) indicated, 
and were compared using ANOVA, paired and unpaired t-tests as indicated in the text (Prism 
8, GraphPad Software, Inc., San Diego CA, USA) using a statistical significance (*) of P < 
0.05. Our experiments were conducted on ICG neurons of in situ preparations each from 
individual adult rats (N = 20), and animals were not randomized.  
 
Results 
The action of ketamine on the passive membrane properties of the postganglionic ICG 
neurons  
All ICG neurons investigated had a resting membrane potential  40 mV, overshooting 
somatic action potentials evoked by short depolarizing current pulses (2-3 ms) and received 
excitatory input due to spontaneous transmitter release from the vagus or interganglionic 
nerve terminals. Recordings were stable for at least 15 mins before readings were taken and 
the superfusing solution was altered. The passive membrane properties, resting membrane 
potential and input resistance, were in good agreement with previous reports for adult rat ICG 
neurons in situ (Rimmer and Harper, 2006).  
Ketamine evoked a concentration-dependent hyperpolarization (< 5 mV) of the resting 
membrane potential. Superfusion of 100 M ketamine, the maximum concentration tested, 
significantly produced a hyperpolarizing shift in the mean resting membrane potential from 
49.6  4.2 mV to 51.6  3.9 mV (n = 10, *paired t-test). The input resistance of ICG 
neurons was also reversibly increased by ~30% in the presence of 100 M ketamine from a 
mean value of 111.5  47.6 Mto 146.7  58.1 M (n = 10, *paired t-test) (see Figure 1). 
The directly-evoked action potential overshoot and duration at the 0 mV level were not 
significantly affected by 100 µM ketamine (12.7  4.2 mV and 0.87  0.10 ms, control and 
11.1  3.4 mV and 0.90  0.17 ms in the presence of ketamine, n = 8, *paired t-test). The 
effect of 100 µM ketamine was also investigated on depolarization-activated Ca
2+
 currents 
mediated by human Cav2.1 (P/Q-type), Cav2.2 (N-type) and Cav2.3 (R-type) channels 
expressed in HEK293 cells (n = 3 for each) (Figure S1). Ketamine (100 µM) did not inhibit 
Ca
2+
 current amplitude mediated by any of the neuronal Cav2 channels which is consistent 
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with its lack of effect on the action potential. 
 
 Effect of ketamine on synaptic transmission in ICG  
All ICG neurons investigated received a secure/suprathreshold excitatory input following 
nerve stimulation (Rimmer and Harper, 2006). Nerve stimuli were normally delivered at 0.2 
Hz at twice threshold intensity (voltage). A synaptic potential was normally observed as an 
inflection on the falling phase and after-hyperpolarization of the action potential.  The impact 
of ketamine on the ability of the postganglionic neuron to follow the activity of pre-
ganglionic stimuli at different frequencies (normally 5-100 Hz) was studied. Trains of stimuli 
(20), with intervening recovery periods of 30 s, were applied and action potential discharge 
monitored in the postganglionic neuronal soma. Synaptic efficacy was used to provide an 
objective index of the frequency dependence of synaptic transmission. This was determined 
as the percentage of postsynaptic action potentials as a function of nerve stimulation 
frequency plotted on a logarithmic scale (Smith et al., 2016). The number of successful 
somatic action potentials (normally constant to 20 Hz) decreased as the frequency of the train 
of stimuli increased (see Figure 2). Figure 2 A (i-vi) presents progressive block of ganglionic 
transmission at 50 Hz by superfusion of increasing concentrations of ketamine. The 
concentration-dependence of ketamine’s action on synaptic efficacy for 2-100 Hz for a 
representative neuron is presented in Figure 2B.  Given that a fraction of neurons within the 
ICG have been reported to be afferent in nature (Edwards et al., 1995), CdCl2 (100 M) was 
applied at the end of the experimental manoeuvres to test and substantiate that the response 
was synaptically mediated, and not due to antidromic conduction (Rimmer and Harper, 
2006).  
Ganglionic transmission is progressively decreased with increasing concentrations of 
ketamine, however, statistical analysis relationship is obscured by the distinct frequency 
dependence of synaptic efficacy between individual ICG neurons. Whereas for all neurons 
studied synaptic efficacy was 100% at 5 Hz and this was reduced to 68.4  34.1% (n = 8; 
range 15-100 %) at 50 Hz (approximating maximum cardiac vagal efferent frequency, Kunze 
1972). To circumvent this issue, the data were expressed as a percentage of that recorded in 
control conditions for each test frequency as shown in Figure 3. Synaptic transmission was 
unaffected by 10 M ketamine at low frequencies but was significantly blunted at 50 and 100 
Hz (one-way ANOVA, Tukey’s multiple comparison test). Stimulus frequencies of 20 and 10 
Hz required ketamine concentrations of 50 and 100 M, respectively, to achieve significant 
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reduction of synaptic efficacy. Even at the highest concentration of ketamine tested (100 
M), ganglionic transmission was not completely blocked, the first stimulus of the train 
evoking an action potential in the postganglionic neuron, for example see Figure 2A(v). 
 
Action of ketamine on excitatory ACh- and nicotine-evoked membrane potential responses 
in adult rat ICG neurons.  
The action of ketamine on nAChRs was assayed by focal application of ACh and nicotine 
(100 M, 20 or 50 ms). Under control conditions, this challenge evoked a transient 
depolarizing membrane potential response and multiple, adapting, action potential discharge. 
The peak depolarization evoked by either ACh (mean 20.9 mV, median 21.2  9.3 mV, n = 5) 
or nicotine (mean 16.8 mV, median 15.1  6.4 mV, n = 5) was blunted by ketamine. Figure 
4A and B illustrate the decrease of the peak transient depolarization evoked by ACh and 
nicotine by superfusion of ketamine (50 and 100 M). Figure 4C shows the reduction of 
depolarization with ketamine concentration. The extent of inhibition by 50 M ketamine was 
similar for both ACh- and nicotine-evoked depolarizations reduced to 0.63  0.08 and 0.74  
0.09 (n = 5) of control values for ACh and nicotine, respectively.  The effect of 100 M 
ketamine was significantly greater for ACh than for nicotine with peak depolarization 
reduced to 0.31  0.11 and 0.54  0.13 (n = 5) of control values, respectively (*unpaired t-
test).  
Immunohistochemical staining using antibodies against GABA demonstrated that 
GABA is present in some processes but primarily in the somata of ICG neurons (Fischer et 
al., 2005). However, there is no evidence for GABAergic pathways projecting to the heart. 
Therefore, this suggests that putative GABA release from ICG neurons may act in an 
autocrine or paracrine fashion to regulate ganglionic transmission. Focal application of 
GABA (100 M) evoked a transient membrane depolarization of ~10 mV amplitude 
mediated by GABAA receptors expressed in adult rat ICG neurons in situ (Fischer et al., 
2005). In the present study, the depolarization induced by focal application of GABA was 
observed in all neurons studied of adult rat ICG preparations (N = 3) and bath application of 
ketamine (100 M) had no effect on the GABA-mediated excitatory responses in those 
neurons (Figure 4D).  
 
The action of ketamine on nicotine- and ACh-evoked currents.  
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Membrane current responses to focal nicotine (and ACh) application were recorded using the 
discontinuous single electrode voltage clamp (dSEVC). The somatic Inicotine/ACh were taken 
after balancing the bridge and neutralising electrode capacitance in discontinuous current 
clamp mode.  Gain was adjusted such that the membrane potential response during agonist 
application was   2 mV. The peak membrane current evoked by focal application of nicotine 
(100 M) under control conditions at a holding potential of 50 mV was 0.85  0.37 nA (n 
= 5). Representative current recordings in response to nicotine in the absence (control, 
recovery) and presence of ketamine (50 and 100 M) are shown in Figure 5A. Ketamine 
reduced the ACh- and nicotine-evoked currents in a concentration-dependent manner (Figure 
5B). The mean half-maximal inhibitory concentration (IC50) obtained for ketamine inhibition 
of nicotine-evoked currents was 44.1 M (n ≥ 5). Ketamine inhibition of ACh-evoked 
membrane currents exhibited a similar IC50 as shown in Figure 5B.   
Families of currents elicited by brief pulses of ACh recorded from a voltage-clamped 
neuron at various membrane potentials in the absence (control) and presence of ketamine (20, 
50 and 100 M) are shown in Figure 6A. The inhibition of ACh-evoked currents by ketamine 
is consistent with the previously reported effect of ketamine on nAChR-mediated Ca
2+
 
transients in dissociated rat ICG neurons (Weber et al., 2005). Increasing concentrations of 
ketamine reduced the amplitude of ACh-evoked currents recorded at various holding 
potentials is shown in Figure 6B. The voltage-dependence of ketamine block is reflected in 
that the inhibition of ACh-evoked peak current amplitude by 100 µM ketamine was more 
than threefold greater at 90 mV compared to 30 mV. The extent of ketamine inhibition as a 
function of membrane potential is similar to that observed for α3β4 nAChRs expressed in 
Xenopus oocytes (Yamakura et al., 2000). Voltage-dependent inhibition of nAChR-mediated 
currents whereby the degree of inhibition increased with membrane hyperpolarization, 
suggests that ketamine is entering the membrane electric field and blocking the open nAChR-




The increasing use of ketamine as a potential rapid-onset antidepressant (Zanos and 
Gould, 2018; Villas Boas et al., 2019) necessitates a better understanding of its effects on 
blood pressure and heart rate, well-known side effects at higher doses. Furthermore, it is 
recognised that abuse of or chronic treatment with ketamine cause ventricular structural and 
functional alterations which lead to alterations in cardiac electrophysiological properties and 
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increase the susceptibility to arrhythmias (Li et al., 2012). In this study, we have directly 
tested the proposal that ketamine inhibits nAChR-mediated currents in rat ICG neurons. 
Ketamine blunted cholinergic ganglionic transmission which accounts for the action of 
ketamine on vagal transmission to the heart (Inoue and König, 1988). Ketamine block was 
progressive, with secure transmission being recorded before ensuing subthreshold EPSPs. 
This could be the result of ketamine suppressing transmitter release at the preganglionic 
nerve terminals or block of the postganglionic nAChRs. However, ketamine (100 µM) had no 
significant effect on action potential overshoot or duration in ICG neurons and we have 
previously been shown that depolarization-activated calcium channel currents in rat ICG 
neurons were unaffected in the presence of 10 M ketamine (Weber et al., 2005). 
Furthermore, 10 μM ketamine has been shown to have no effect on high voltage-activated 
(HVA) Ca
2+
 currents in rat hippocampal neurons and at 100 μM reduced the peak HVA Ca
2+
 
currents by only 25.5 ± 6.9% and shifted the inactivation curve (~5 mV) to more 
hyperpolarized potentials (Tan et al., 2010). Our results also show that the predominant 
presynaptic calcium channels mediating synaptic transmission, Cav2.1, Cav2.2 and Cav2.3, 
were not significantly inhibited by 100 µM ketamine (Figure S1). Ketamine reduced 





currents with IC50’s >100 µM (Schnoebel et al., 2005) and, in differentiated hippocampal 
H19-7 cells, 100 µM ketamine reduced Na
+





 currents with an IC50 of 274 µM (Huang et al., 2012). In identified cardiac 
parasympathetic preganglionic neurons in nucleus ambiguus of the rat brainstem slice 
preparation, the current-voltage relations for the transient K
+
 current and delayed rectifier K
+
 
current were unaltered by ketamine (10 µM -1 mM) whereas the peak Na
+
 current amplitude 
was reversibly inhibited (Irnaten et al., 2002). Ketamine inhibited tetrodotoxin (TTX)-
sensitive and TTX-resistant Na
+
 channels in rat dorsal root ganglion neurons with IC50s of 
147 µM and 866 µM, respectively (Zhou and Zhao, 2000), and human neuronal Na
+
 channels 
natively expressed in SH-SY5Y cells with an IC50 of 1140 µM (Reckziegel et al., 2002). 





channels is unlikely to make any substantive contribution to ketamine inhibition of synaptic 
transmission in ICG.  
Ketamine has been shown to inhibit several subtypes of neuronal nAChRs (Coates and 
Flood, 2001; Flood and Krasowski, 2000; Furuya et al., 1999; Yamakura et al., 2000), 
although the homomeric 7 nAChR appears less sensitive (Tassonyi et al., 2002). nAChRs 
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principally comprised of β subunits have been held to be more sensitive than those mainly of 
α subunits (Zanos et al., 2018; Yamakura et al., 2000). Ketamine, a non-competitive 
antagonist at neuronal nAChRs, has been shown to be most potent (IC50 = 9.5 µM) at rat 
α3β4 nAChRs expressed in Xenopus oocytes (Yamakura et al., 2000). The α3β4 nAChR 
subtype is the predominant nAChR subtype expressed in cardiac parasympathetic ganglion 
neurons (Bibevski et al., 2000; Poth et al., 1997), and most likely to contribute significantly 
to vagal synaptic transmission in the mammalian heart. However, human α3β4 nAChRs 
exhibit a different stoichiometry in mammalian HEK293 cells ((α3)3(β4)2) compared to that 
when expressed in Xenopus oocytes ((α3)2(β4)3) which is reflected in a lower ACh sensitivity 
and higher single channel conductance (Krashia et al., 2010). This may contribute to a 
different potency of ketamine inhibition of neuronal ACh-evoked currents and vagal synaptic 
transmission in mammalian ICG neurons. Furthermore, the present study was limited to 
postganglionic neurones receiving strong/secure inputs having a high safety factor for 
transmission of impulses (Rimmer and Harper, 2006). 
The inhibition of EPSP amplitude was significant at clinically relevant concentrations 
at high stimulation frequencies.  Ketamine used at clinical half-maximal effective 
concentration had previously been shown to inhibit nAChR-mediated increases in [Ca
2+
]i by 
∼40% (Weber et al., 2005). As the ketamine concentration was increased, block of 
ganglionic transmission was apparent at successively lower frequencies. Inspecting 
presynaptic nerve stimulation frequencies reveals a broad range in the efficacy of ganglionic 
transmission in ICG neurons at  20 Hz (Smith et al., 2016). To our knowledge, there is little 
data available on the frequency of parasympathetic cardiac efferents targeting ICG neurons in 
the rat. In the Working Heart-Brainstem Preparation (WHBP) application of strong reflex 
stimuli (baroreceptor and peripheral chemoreceptor) evoked a substantial increase in synaptic 
activity in ICG neurons, maximum EPSP frequency of 55 and 65 Hz for baro- and chemo-
receptor stimuli, respectively (McAllen et al., 2011). However, since the perfusion 
temperature in the WHBP preparation was 32C these frequencies are, in all likelihood, an 
underestimation of those relevant to physiological temperature.  
The excitatory membrane potential and current responses to focal application of 
exogenous ACh and nicotine were reversibly inhibited in a concentration-dependent manner 
by ketamine. Ketamine (100 M) had no effect on the excitatory responses evoked by focal 
application of GABA in rat ICG neurons in situ. Taken together, ketamine inhibits ACh-
evoked responses and synaptic transmission in rat ICG and therefore attenuates the 
13 
 
bradycardia observed in response to vagal stimulation in the mammalian heart. Impaired 
parasympathetic control is a powerful independent prognostic indicator of arrhythmia. 
Reduction of transmission in the ICG will produce a sympatho-vagal imbalance, resulting in 
a dominance of sympathetic pro-arrhythmic activity (Kalla et al., 2016). The role of the ICG 
in modulating extrinsic autonomic input to the heart and atrial fibrillation initiation is being 
increasingly recognised (Choi et al., 2017; Gibbons et al., 2012; Hou et al., 2007). Ketamine 
has also been demonstrated to reduce transmission in mammalian sympathetic ganglia (Juang 
et al., 1980; Mahmoodi et al., 1980) and both tachycardia and bradycardia have been 
described with ketamine administration (Akine et al., 2001; Blake and Korner, 1981, 1982). 
These differences may be due to the impact of ketamine on ganglionic transmission on the 
prevailing balance of sympatho-vagal drive regulating cardiac rhythm. 
At physiological pH (7.4) there will be approximately equal amounts of the protonated 
and uncharged forms of the racemic mixture of ketamine, given its experimental pKa being 
7.5. The ionization of ketamine influences its pH-dependent potency whereby the potency for 
(±) ketamine inhibition of recombinant NMDA (GluN1/GluN2A) receptors expressed in 
Xenopus oocytes is increased 6.9-fold at pH 6.9 compared to pH 7.6 (Dravid et al., 2007). 
Processes which lower extracellular pH, for example in myocardial ischaemia (approx. pH 
6.1; Clarke et al., 1993) will enhance the fraction of charged ketamine. If the pH dependence 
of inhibition of NMDA receptor-channels extends to nAChRs, it would be anticipated to 
enhance block of nAChRs and synaptic transmission in mammalian ICG.  The cardiovascular 
effects of ketamine, in particular, its positive chronotropic action by inhibiting nAChRs in 
postganglionic ICG neurons, may well be exacerbated in cardiovascular disease states. 
Clinically, the plasma concentration of ketamine peaks at 10-60 µM during general 
anesthesia after intravenous administration of 2 mg.kg
1
 (Idvall et al., 1979) which is 
consistent with the concentration-dependence of ketamine inhibition of nAChRs and synaptic 
transmission in mammalian ICG.  In conclusion, our results indicate that ketamine inhibition 
of synaptic transmission in rat ICG is concentration- and frequency-dependent primarily due 
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Figure 1.  Current-voltage relationship of adult rat intracardiac ganglion (ICG) neurons in the 
absence (control) and presence of ketamine. A, voltage responses obtained in response to 
long depolarizing and hyperpolarizing current pulses (+0.1, 0.1 to 0.5 nA) are shown for 
control conditions (i) and in the presence of ketamine (ii, 100 M). B, current-voltage (I-V) 
relations for each condition plotted for the peak voltage response (,) and the steady state 
response measured at the end of the current step (,).  
 
Figure 2.  The action of ketamine on ganglionic transmission in adult rat ICG neurons. 
Waterfall displays of postsynaptic responses to 20 stimuli at 50 Hz applied at time “s” are  
shown. Responses to a train of such stimuli delivered to the preganglionic nerve trunk in 
control conditions, A(i) and progressive block of ganglionic transmission by superfusion of 
ketamine A(ii), 10 M; A(iii), 20 M; A(iv), 50 M;  A(v), 100 M, and A(vi) washout, 
recovery are presented. B, frequency dependence (synaptic efficacy) of ganglionic 
transmission in control conditions and increasing concentrations of ketamine. Data presented 
for the exemplar neuron shown in A (i-vi).   
  
Figure 3.  The action of ketamine on the frequency dependence of ganglionic transmission. 
Ketamine attenuated synaptic efficacy in a concentration-dependent manner. The results are 
expressed as a percentage of that recorded in control conditions for each test frequency (log 
scale). Evidence of blunting of synaptic efficacy at low concentrations of ketamine was 
apparent at high frequencies (data shown as mean  SD, n ≥ 5 neurons except for 100 µM 
ketamine, n = 4). Synaptic transmission was significantly decreased by 10 M ketamine at 50 
and 100 Hz (n = 7, *one-way ANOVA, Tukey’s multiple comparison test). 
 
Figure 4.  Effect of ketamine on ACh- and nicotine-evoked voltage (Em) responses in ICG 
neurons. A (i-iii) example of the action of 50 and 100 M ketamine on focal application of 
ACh (20 ms), and B (i-iii)  nicotine, application indicated by arrowhead. Focal application of 
these agents in control conditions evoked transient depolarizing responses and action 
potential discharge. C, plots of the action of ketamine (log scale) on the peak, with time, 
depolarizing responses to ACh and nicotine. Data expressed as a fraction of that recorded in 
control conditions. D, Focal application of GABA (100 M, 50 ms) evoked membrane 
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depolarization and action potential firing. Ketamine (100 µM) had no effect on the GABA-
evoked excitatory responses.   
 
Figure 5.  The action of ketamine on nAChR-mediated currents activated by focal application 
of nicotine at a holding potential of 50 mV. A(i) control, (ii) 50 and (iii) 100 M ketamine, 
respectively, and (iv) washout/ recovery. B, log concentration-response relationship of the 
action of ketamine on ACh- and nicotine-evoked membrane currents. Data expressed as mean 
 SD (n ≥ 5 for each [ACh], n indicated for each [nicotine]).  
 
Figure 6.  The action of ketamine on ACh-evoked currents (IACh) in rat ICG neurons. A, 
families of  membrane currents evoked by focal application of ACh recorded from a voltage-
clamped  (dSEVC) neuron at various membrane potentials, 30, 50, 70 and 90 mV  in the 
absence (control) and presence of 20 and 100 M ketamine (Ket). B, current-voltage 
relationships for (IACh) amplitude in absence (control, washout) and presence of ketamine (20, 
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